跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZITHROMYCIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AZITHROMYCIN
Authorized
STANDARD
AZITHROMYCIN
altamed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2e4aa6e389cd6df3
Company
altamed pharma
Type
Standard
Approval Details
Approval Id
2e4aa6e389cd6df3
Drug Approval Canada Name
AZITHROMYCIN
Product Name
AZITHROMYCIN
Status
Cancelled Post Market
Status Date
2022-06-13
Original Market Date
2019-05-07
Din
02477610
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.12.08
Atc Original
J01FA10 AZITHROMYCIN
Atc Name
j 01 fa 10
Aig Number
0126072001
Company Name
altamed pharma
Company Address
151 Boulevard De Mortagne, Boucherville, Quebec, Canada, J4B 6G4
Active Ingredients
AZITHROMYCIN (AZITHROMYCIN DIHYDRATE)
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2e4aa6e389cd6df3
Type
Standard
Back to Health Canada Approvals